-
1
-
-
10744228523
-
Adult cardiac stem cells are multipotent and support myocardial regeneration
-
Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-76.
-
(2003)
Cell
, vol.114
, pp. 763-776
-
-
Beltrami, A.P.1
Barlucchi, L.2
Torella, D.3
-
2
-
-
70449704532
-
Cell-based therapy for ischemic heart disease: a clinical update
-
Herrmann JL, Abarbanell AM, Weil BR, et al. Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg. 2009; 88: 1714-22.
-
(2009)
Ann Thorac Surg
, vol.88
, pp. 1714-1722
-
-
Herrmann, J.L.1
Abarbanell, A.M.2
Weil, B.R.3
-
3
-
-
70350131483
-
Generation of functional ventricular heart muscle from mouse ventricular progenitor cells
-
Domian IJ, Chiravuri M, van der Meer P, et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science. 2009; 326: 426-9.
-
(2009)
Science
, vol.326
, pp. 426-429
-
-
Domian, I.J.1
Chiravuri, M.2
van der Meer, P.3
-
4
-
-
0036142213
-
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart the adult murine heart
-
Toma C, Mark F. Pittenger MF, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart the adult murine heart. Circulation. 2002; 105: 93-8.
-
(2002)
Circulation
, vol.105
, pp. 93-98
-
-
Toma, C.1
Mark, F.2
Pittenger, M.F.3
-
5
-
-
73449130151
-
Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase
-
Fischer KM, Cottage CT, Wu W, et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation. 2009; 120: 2077-87.
-
(2009)
Circulation
, vol.120
, pp. 2077-2087
-
-
Fischer, K.M.1
Cottage, C.T.2
Wu, W.3
-
6
-
-
48049109419
-
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function
-
Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008; 103: 107-16.
-
(2008)
Circ Res
, vol.103
, pp. 107-116
-
-
Rota, M.1
Padin-Iruegas, M.E.2
Misao, Y.3
-
7
-
-
70349143140
-
Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction
-
Yao Y, Zhang F, Wang L, et al. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. J Biomed Sci. 2009; 16: 74.
-
(2009)
J Biomed Sci
, vol.16
, pp. 74
-
-
Yao, Y.1
Zhang, F.2
Wang, L.3
-
8
-
-
73849116441
-
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts
-
Yang YJ, Qian HY, Huang J, et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol. 2009; 29: 2076-82.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 2076-2082
-
-
Yang, Y.J.1
Qian, H.Y.2
Huang, J.3
-
9
-
-
77950861884
-
Functional recovery of diabetic mice hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO signaling network
-
Lekli I, Mukherjee S, Ray D, et al. Functional recovery of diabetic mice hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO signaling network. Gene Therapy. 2010; 17: 478-85.
-
(2010)
Gene Therapy
, vol.17
, pp. 478-485
-
-
Lekli, I.1
Mukherjee, S.2
Ray, D.3
-
10
-
-
61449176031
-
Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein
-
Gurusamy N, Lekli I, Gorbunov NV, et al. Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med. 2009; 13: 373-87.
-
(2009)
J Cell Mol Med
, vol.13
, pp. 373-387
-
-
Gurusamy, N.1
Lekli, I.2
Gorbunov, N.V.3
-
11
-
-
67349189553
-
Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose
-
Dudley J, Das S, Mukherjee S, et al. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem. 2009; 20: 443-52.
-
(2009)
J Nutr Biochem
, vol.20
, pp. 443-452
-
-
Dudley, J.1
Das, S.2
Mukherjee, S.3
-
12
-
-
74949098826
-
Grapes, Wines, Resveratrol and Heart Health
-
Bertelli AA, Das DK. Grapes, Wines, Resveratrol and Heart Health. J Cardiovasc Pharmacol. 2009; 54: 468-76.
-
(2009)
J Cardiovasc Pharmacol
, vol.54
, pp. 468-476
-
-
Bertelli, A.A.1
Das, D.K.2
-
13
-
-
70449704532
-
Cell-based therapy for ischemic heart disease: a clinical update
-
Herrmann JL, Abarbanell AM, Weil BR, et al. Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg. 2009; 88: 1714-22.
-
(2009)
Ann Thorac Surg
, vol.88
, pp. 1714-1722
-
-
Herrmann, J.L.1
Abarbanell, A.M.2
Weil, B.R.3
-
14
-
-
0036968298
-
The protective effect of resveratrols on ischaemiareperfusion injuries of rat hearts is correlated with antioxidant efficacy
-
Hung LM, Su MJ, Chu WK, et al. The protective effect of resveratrols on ischaemiareperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol. 2002; 135: 1627-33.
-
(2002)
Br J Pharmacol
, vol.135
, pp. 1627-1633
-
-
Hung, L.M.1
Su, M.J.2
Chu, W.K.3
-
15
-
-
26844449558
-
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
-
Kaga S, Zhan L, Matsumoto M, et al. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol. 2005; 39: 813-22.
-
(2005)
J Mol Cell Cardiol
, vol.39
, pp. 813-822
-
-
Kaga, S.1
Zhan, L.2
Matsumoto, M.3
-
16
-
-
33745962138
-
Therapeutic potential of resveratrol: the in vivo evidence
-
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5: 493-6.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 493-496
-
-
Baur, J.A.1
Sinclair, D.A.2
-
17
-
-
0027447124
-
Inhibition of human LDL oxidation by resveratrol
-
Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993; 341: 1103-4.
-
(1993)
Lancet
, vol.341
, pp. 1103-1104
-
-
Frankel, E.N.1
Waterhouse, A.L.2
Kinsella, J.E.3
-
18
-
-
0037414403
-
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity
-
Floreani M, Napoli E, Quintieri L, et al. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci. 2003; 72: 2741-50.
-
(2003)
Life Sci
, vol.72
, pp. 2741-2750
-
-
Floreani, M.1
Napoli, E.2
Quintieri, L.3
-
19
-
-
73149085941
-
Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species
-
Imhoff BR, Hansen JM. Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species. Biochem J. 2009; 424: 491-500.
-
(2009)
Biochem J
, vol.424
, pp. 491-500
-
-
Imhoff, B.R.1
Hansen, J.M.2
-
20
-
-
70350115341
-
Nrf2 protects against maladaptive cardiac responses to hemodynamic stress
-
Li J, Ichikawa T, Villacorta L, et al. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler Thromb Vasc Biol. 2009; 29: 1843-50.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1843-1850
-
-
Li, J.1
Ichikawa, T.2
Villacorta, L.3
-
21
-
-
33748893228
-
Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion
-
Osburn WO, Wakabayashi N, Misra V, et al. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys. 2006; 454: 7-15.
-
(2006)
Arch Biochem Biophys
, vol.454
, pp. 7-15
-
-
Osburn, W.O.1
Wakabayashi, N.2
Misra, V.3
-
22
-
-
49049106335
-
Activation of Nrf2 in defense against cadmium-induced oxidative stress
-
He X, Chen MG, Ma Q. Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem Res Toxicol. 2008; 21: 1375-83.
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 1375-1383
-
-
He, X.1
Chen, M.G.2
Ma, Q.3
-
23
-
-
33750532308
-
Regulation of inflammation and redox signaling by dietary polyphenols
-
Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006; 72: 1439-52.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 1439-1452
-
-
Rahman, I.1
Biswas, S.K.2
Kirkham, P.A.3
-
24
-
-
44849083150
-
Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation
-
Ding Y, Choi KJ, Kim JH, et al. Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation. Am J Pathol. 2008; 172: 1529-41.
-
(2008)
Am J Pathol
, vol.172
, pp. 1529-1541
-
-
Ding, Y.1
Choi, K.J.2
Kim, J.H.3
-
25
-
-
34548276529
-
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
-
Fishel ML, Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med. 2007; 28: 375-95.
-
(2007)
Mol Aspects Med
, vol.28
, pp. 375-395
-
-
Fishel, M.L.1
Kelley, M.R.2
-
26
-
-
30344434348
-
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor
-
Yang S, Irani K, Heffron SE, et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther. 2005; 4: 1923-35.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 1923-1935
-
-
Yang, S.1
Irani, K.2
Heffron, S.E.3
|